AAN Aaron's | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.56 +3.7% | $9.00 ➝ $8.00 | Hold ➝ Hold | |
ABCL AbCellera Biologics | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.84 -5.0% | $8.00 ➝ $7.00 | Overweight ➝ Overweight | |
ACCD Accolade | Target Lowered by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.12 -4.3% | $17.00 ➝ $13.00 | Buy ➝ Buy | |
ACM AECOM | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.27 -0.9% | $106.00 ➝ $113.00 | Buy ➝ Buy | |
ADTN ADTRAN | Upgraded by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.47 +1.5% | $7.50 | Market Perform ➝ Outperform | |
ADTN ADTRAN | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.47 +1.5% | $8.00 | Buy ➝ Buy | |
|
AEVA Aeva Technologies | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.48 +0.9% | $10.00 ➝ $7.00 | Buy ➝ Buy | |
AFRM Affirm | Reiterated by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.58 -9.5% | | Neutral | |
AGM Federal Agricultural Mortgage | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $179.01 +3.3% | $225.00 ➝ $212.00 | Outperform ➝ Outperform | |
ALAB Astera Labs | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.26 -9.1% | $85.00 | Buy ➝ Buy | |
ALHC Alignment Healthcare | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.78 -1.3% | $6.00 ➝ $8.00 | Neutral ➝ Overweight | |
AMBC Ambac Financial Group | Target Raised by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.32 +1.6% | $18.00 ➝ $19.00 | Buy ➝ Buy | |
AMRK A-Mark Precious Metals | Downgraded by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.15 -5.4% | | Outperform ➝ Market Perform | |
ANET Arista Networks | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67 +6.5% | $275.00 ➝ $285.00 | Neutral ➝ Neutral | |
ANET Arista Networks | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67 +6.5% | $320.00 | Buy ➝ Buy | |
ANET Arista Networks | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67 +6.5% | $268.00 ➝ $302.00 | Neutral ➝ Neutral | |
ANET Arista Networks | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67 +6.5% | $310.00 ➝ $340.00 | Overweight ➝ Overweight | |
ANET Arista Networks | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67 +6.5% | $306.00 ➝ $349.00 | Overweight ➝ Overweight | |
APEI American Public Education | Target Raised by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.87 +17.7% | $17.00 ➝ $20.00 | Outperform ➝ Outperform | |
APLM Apollomics | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.41
| $5.00 ➝ $2.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30 -3.6% | $92.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30 -3.6% | $67.00 ➝ $60.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30 -3.6% | $89.00 ➝ $85.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30 -3.6% | $85.00 | Buy ➝ Buy | |
APTV Aptiv | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.20 +0.2% | $92.00 ➝ $94.00 | Buy ➝ Buy | |
ARMK Aramark | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.87 +3.6% | $35.00 ➝ $37.00 | Neutral ➝ Neutral | |
ARVN Arvinas | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37 -5.7% | $72.00 ➝ $68.00 | Buy ➝ Buy | |
ARVN Arvinas | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37 -5.7% | $87.00 | Buy ➝ Buy | |
ARVN Arvinas | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37 -5.7% | $57.00 | Outperform ➝ Outperform | |
ASTH Astrana Health | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.09 +0.4% | $50.00 ➝ $45.00 | Buy ➝ Buy | |
ATEC Alphatec | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.60 -21.9% | $23.00 | Buy ➝ Buy | |
ATEC Alphatec | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.60 -21.9% | $19.00 ➝ $17.00 | Overweight ➝ Overweight | |
ATER Aterian | Upgraded by | Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.78 +9.4% | | Neutral ➝ Buy | |
ATKR Atkore | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.69 +2.2% | $200.00 ➝ $188.00 | Neutral ➝ Neutral | |
ATSG Air Transport Services Group | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.59 -0.8% | $16.00 ➝ $18.00 | Buy ➝ Buy | |
ATSG Air Transport Services Group | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.59 -0.8% | $14.00 ➝ $15.00 | Neutral ➝ Neutral | |
AUDC AudioCodes | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.88 -0.4% | $12.00 ➝ $10.00 | Underweight ➝ Underweight | |
AVDL Avadel Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.25 -10.6% | $22.00 | Buy ➝ Buy | |
AVNT Avient | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12 -2.6% | $49.00 ➝ $53.00 | Buy ➝ Buy | |
AVNT Avient | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12 -2.6% | $50.00 ➝ $52.00 | Overweight ➝ Overweight | |
Elon Musk Secret Crypto Plot Exposed (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
AVY Avery Dennison | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $225.10 +0.5% | $240.00 ➝ $245.00 | Buy ➝ Buy | |
AXON Axon Enterprise | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $311.86 -0.3% | $308.00 ➝ $381.00 | Overweight ➝ Overweight | |
AXSM Axsome Therapeutics | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.68 -1.6% | $109.00 ➝ $106.00 | Buy ➝ Buy | |
AZPN Aspen Technology | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.79 +4.8% | $225.00 ➝ $210.00 | Outperform ➝ Outperform | |
AZPN Aspen Technology | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.79 +4.8% | $196.00 ➝ $180.00 | Neutral ➝ Neutral | |
BAND Bandwidth | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15 -6.2% | $21.00 ➝ $25.00 | Neutral ➝ Neutral | |
BAND Bandwidth | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15 -6.2% | $21.00 ➝ $32.00 | Overweight ➝ Overweight | |
BAND Bandwidth | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15 -6.2% | $22.00 ➝ $28.00 | Overweight ➝ Overweight | |
BAND Bandwidth | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15 -6.2% | $32.00 ➝ $36.00 | Market Outperform ➝ Market Outperform | |
BAND Bandwidth | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15 -6.2% | $38.00 ➝ $40.00 | Buy ➝ Buy | |
BEAM Beam Therapeutics | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.24 -1.3% | $42.00 ➝ $33.00 | Equal Weight ➝ Equal Weight | |
BIO Bio-Rad Laboratories | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $268.26 -4.2% | $420.00 ➝ $385.00 | Buy ➝ Buy | |
BL BlackLine | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.51 -1.5% | $61.00 ➝ $72.00 | Outperform ➝ Outperform | |
BL BlackLine | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.51 -1.5% | $65.00 ➝ $67.00 | Market Perform ➝ Market Perform | |
BLD TopBuild | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $396.55 0.0% | $450.00 ➝ $470.00 | Buy ➝ Buy | |
BLDP Ballard Power Systems | Target Lowered by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $3.75 ➝ $3.50 | Neutral ➝ Neutral | |
BLDP Ballard Power Systems | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $3.50 ➝ $3.25 | Hold | |
BLDP Ballard Power Systems | Target Lowered by | National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $4.50 ➝ $4.00 | Sector Perform | |
BLDP Ballard Power Systems | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $2.50 ➝ $2.75 | Hold | |
BLDP Ballard Power Systems | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $4.10 ➝ $3.80 | Buy ➝ Buy | |
BLDP Ballard Power Systems | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88 +1.4% | $3.50 ➝ $3.00 | Hold ➝ Hold | |
BLDR Builders FirstSource | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46 +0.5% | $190.00 ➝ $180.00 | Hold ➝ Hold | |
BLDR Builders FirstSource | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46 +0.5% | $207.00 ➝ $197.00 | Neutral ➝ Neutral | |
BLDR Builders FirstSource | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46 +0.5% | $240.00 ➝ $200.00 | Overweight ➝ Overweight | |
BLMN Bloomin' Brands | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89 -0.3% | $32.00 ➝ $30.00 | Overweight ➝ Overweight | |
BLMN Bloomin' Brands | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89 -0.3% | $29.00 ➝ $27.00 | Market Perform ➝ Market Perform | |
BLMN Bloomin' Brands | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89 -0.3% | $30.00 ➝ $26.00 | Neutral ➝ Neutral | |
BNTX BioNTech | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.13 -0.8% | $107.00 ➝ $113.00 | Buy ➝ Buy | |
BP BP | Target Raised by | TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.53 -0.1% | $43.00 ➝ $44.00 | Buy | |
BRBR BellRing Brands | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.09 -0.6% | $64.00 ➝ $70.00 | Buy ➝ Buy | |
BRBR BellRing Brands | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.09 -0.6% | $60.00 ➝ $65.00 | Outperform ➝ Outperform | |
BRBR BellRing Brands | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.09 -0.6% | $60.00 ➝ $68.00 | Buy ➝ Buy | |
BRBR BellRing Brands | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.09 -0.6% | $63.00 ➝ $67.00 | Buy ➝ Buy | |
BROS Dutch Bros | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.76 +11.8% | $37.00 ➝ $39.00 | Outperform ➝ Outperform | |
BROS Dutch Bros | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.76 +11.8% | $30.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
BSY Bentley Systems | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.36 -1.0% | $57.00 ➝ $60.00 | Buy ➝ Buy | |
BSY Bentley Systems | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.36 -1.0% | $60.00 ➝ $63.00 | Overweight ➝ Overweight | |
BVS Bioventus | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.04 -1.6% | $7.00 ➝ $8.00 | Buy ➝ Buy | |
BWMN Bowman Consulting Group | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.08 -3.5% | $49.00 ➝ $47.00 | Buy ➝ Buy | |
BYON Beyond | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33 -1.2% | $26.00 ➝ $17.00 | Neutral ➝ Neutral | |
BYON Beyond | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33 -1.2% | $43.00 ➝ $37.00 | Outperform ➝ Outperform | |
BYON Beyond | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33 -1.2% | $30.00 ➝ $22.00 | Equal Weight ➝ Equal Weight | |
BYON Beyond | Downgraded by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33 -1.2% | | Buy ➝ Hold | |
BYON Beyond | Target Lowered by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33 -1.2% | $50.00 ➝ $36.00 | Buy ➝ Buy | |
CELH Celsius | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.13 +0.2% | $99.00 ➝ $92.00 | Buy ➝ Buy | |
CFLT Confluent | Reiterated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $33.00 ➝ $36.00 | Buy ➝ Buy | |
CFLT Confluent | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $38.00 | Buy ➝ Buy | |
CFLT Confluent | Upgraded by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $35.00 | Hold ➝ Buy | |
CFLT Confluent | Upgraded by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $28.00 ➝ $35.00 | Hold ➝ Buy | |
CFLT Confluent | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $33.00 ➝ $34.00 | Overweight ➝ Overweight | |
Could this Tiny Biotech End Disease Forever? (Ad) Imagine a revolutionary treatment capable of editing out ANY disease.
By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health. Access my full "Cut & Paste" profit analysis now. |
CFLT Confluent | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $38.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
CFLT Confluent | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $37.00 ➝ $40.00 | Outperform ➝ Outperform | |
CFLT Confluent | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $36.00 ➝ $38.00 | Overweight ➝ Overweight | |
CFLT Confluent | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $35.00 ➝ $37.00 | Buy ➝ Buy | |
CFLT Confluent | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 +12.8% | $34.00 ➝ $37.00 | Buy ➝ Buy | |
CIFR Cipher Mining | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78 -0.5% | $5.50 ➝ $6.00 | Buy ➝ Buy | |
CIFR Cipher Mining | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78 -0.5% | $5.00 | Buy ➝ Buy | |
CLNN Clene | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.39
| $7.00 | Buy ➝ Buy | |
CMTG Claros Mortgage Trust | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.22 -5.2% | $11.00 ➝ $9.00 | Equal Weight ➝ Equal Weight | |
COGT Cogent Biosciences | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.60 -2.1% | $18.00 | Buy ➝ Buy | |
CPNG Coupang | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.47 -9.2% | $20.00 ➝ $23.00 | Neutral ➝ Neutral | |
CPNG Coupang | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.47 -9.2% | $26.00 ➝ $28.00 | Buy ➝ Buy | |
CRBP Corbus Pharmaceuticals | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.39 +6.6% | $58.00 ➝ $60.00 | Outperform ➝ Outperform | |
CRIS Curis | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.35 +0.9% | $26.00 | Buy ➝ Buy | |
CROX Crocs | Target Raised by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.42 -0.8% | $140.00 ➝ $170.00 | Buy | |
CROX Crocs | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.42 -0.8% | $140.00 ➝ $158.00 | Buy ➝ Buy | |
CROX Crocs | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.42 -0.8% | $124.00 ➝ $148.00 | Neutral ➝ Neutral | |
CROX Crocs | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.42 -0.8% | $167.00 ➝ $169.00 | Overweight ➝ Overweight | |
CRS Carpenter Technology | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.53 +1.0% | $100.00 ➝ $140.00 | Buy ➝ Buy | |
CRSR Corsair Gaming | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.79 -8.2% | $18.00 | Outperform ➝ Outperform | |
CRUS Cirrus Logic | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24 +12.2% | $95.00 ➝ $110.00 | Overweight ➝ Overweight | |
CRUS Cirrus Logic | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24 +12.2% | $100.00 ➝ $120.00 | Overweight ➝ Overweight | |
CRUS Cirrus Logic | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24 +12.2% | $100.00 ➝ $110.00 | Buy ➝ Buy | |
CRUS Cirrus Logic | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24 +12.2% | $100.00 ➝ $115.00 | Buy ➝ Buy | |
CRUS Cirrus Logic | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24 +12.2% | $100.00 ➝ $120.00 | Positive ➝ Positive | |
CTV Innovid | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.91 -14.0% | $2.25 ➝ $3.00 | Buy ➝ Buy | |
CURI CuriosityStream | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.15 -6.5% | $1.25 ➝ $1.35 | Buy ➝ Buy | |
CVS CVS Health | Target Lowered by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.93 -1.5% | $100.00 ➝ $80.00 | Buy ➝ Buy | |
CXDO Crexendo | Upgraded by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Nichols Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.94 -15.3% | $6.75 ➝ $5.75 | Neutral ➝ Buy | |
CYRX Cryoport | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.20 -19.5% | $18.00 | Buy ➝ Buy | |
CYTK Cytokinetics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.27 0.0% | $94.00 | Buy ➝ Buy | |
DBVT DBV Technologies | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.67 -1.5% | $10.00 ➝ $5.00 | Buy ➝ Buy | |
DDOG Datadog | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28 +4.3% | $152.00 ➝ $145.00 | Overweight ➝ Overweight | |
DDOG Datadog | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28 +4.3% | $155.00 ➝ $140.00 | Outperform ➝ Outperform | |
DDOG Datadog | Upgraded by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28 +4.3% | $130.00 ➝ $140.00 | Neutral ➝ Outperform | |
DH Definitive Healthcare | Downgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -26.2% | $11.50 ➝ $9.00 | Overweight ➝ Equal Weight | |
DH Definitive Healthcare | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -26.2% | | Hold | |
DH Definitive Healthcare | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -26.2% | $11.00 ➝ $9.50 | Buy ➝ Buy | |
DH Definitive Healthcare | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -26.2% | $10.00 ➝ $8.00 | Hold ➝ Hold | |
DIS Walt Disney | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.46 +0.1% | $130.00 ➝ $128.00 | Outperform ➝ Outperform | |
DIS Walt Disney | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.46 +0.1% | $135.00 ➝ $130.00 | Overweight ➝ Overweight | |
DIS Walt Disney | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.46 +0.1% | $140.00 ➝ $130.00 | Buy ➝ Buy | |
DK Delek US | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.85 -0.3% | $27.00 ➝ $25.00 | Hold ➝ Hold | |
DNLI Denali Therapeutics | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90 +12.2% | $26.00 ➝ $22.00 | Hold ➝ Hold | |
DNLI Denali Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90 +12.2% | $95.00 | Buy ➝ Buy | |
DNLI Denali Therapeutics | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90 +12.2% | $31.00 ➝ $30.00 | Outperform ➝ Outperform | |
DT Dynatrace | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.05 -1.5% | $63.00 ➝ $55.00 | Outperform ➝ Outperform | |
DUK Duke Energy | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.39 +0.1% | $104.00 ➝ $108.00 | Outperform ➝ Outperform | |
DV DoubleVerify | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $48.00 ➝ $40.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $40.00 ➝ $30.00 | Overweight ➝ Overweight | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free. |
DV DoubleVerify | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $40.00 ➝ $34.00 | Market Outperform ➝ Market Outperform | |
DV DoubleVerify | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $49.00 ➝ $40.00 | Outperform ➝ Outperform | |
DV DoubleVerify | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $40.00 ➝ $30.00 | Overweight ➝ Overweight | |
DV DoubleVerify | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $39.00 ➝ $32.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $37.00 ➝ $25.00 | Buy ➝ Buy | |
DV DoubleVerify | Downgraded by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | | Overweight ➝ Sector Weight | |
DV DoubleVerify | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $45.00 ➝ $33.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.77 -38.6% | $42.00 ➝ $34.00 | Outperform ➝ Outperform | |
EA Electronic Arts | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.24 -3.8% | $160.00 ➝ $150.00 | Outperform ➝ Outperform | |
EA Electronic Arts | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.24 -3.8% | $162.00 | Outperform ➝ Outperform | |
ENR Energizer | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29 +1.1% | $33.00 ➝ $32.00 | Hold ➝ Hold | |
ENR Energizer | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29 +1.1% | $33.00 | Underweight ➝ Equal Weight | |
ENR Energizer | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29 +1.1% | $30.00 ➝ $31.00 | Neutral ➝ Neutral | |
ENR Energizer | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29 +1.1% | $35.00 ➝ $30.00 | Hold ➝ Hold | |
ENV Envestnet | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.68 +1.5% | $47.00 ➝ $59.00 | Underperform ➝ Hold | |
ENV Envestnet | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.68 +1.5% | $56.00 ➝ $64.00 | Sector Perform ➝ Sector Perform | |
EOLS Evolus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.26 -1.2% | $27.00 | Buy ➝ Buy | |
EOLS Evolus | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.26 -1.2% | $22.00 | Buy ➝ Buy | |
ESPR Esperion Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04 -13.9% | $16.00 | Buy ➝ Buy | |
EVGO EVgo | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.75 -2.2% | | Hold | |
EXLS ExlService | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.81 +0.4% | $34.00 ➝ $40.00 | Neutral ➝ Outperform | |
EXPD Expeditors International of Washington | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.84 +1.7% | $111.00 ➝ $112.00 | Hold | |
EXPD Expeditors International of Washington | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.84 +1.7% | $112.00 ➝ $120.00 | Neutral ➝ Neutral | |
EYPT EyePoint Pharmaceuticals | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.56 -2.6% | $46.00 ➝ $38.00 | Outperform ➝ Outperform | |
FIS Fidelity National Information Services | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05 -0.3% | $81.00 ➝ $86.00 | Positive ➝ Positive | |
FIS Fidelity National Information Services | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05 -0.3% | $82.00 ➝ $85.00 | Outperform ➝ Outperform | |
FIS Fidelity National Information Services | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05 -0.3% | $70.00 ➝ $75.00 | Hold ➝ Hold | |
FIS Fidelity National Information Services | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05 -0.3% | $75.00 | Outperform ➝ Outperform | |
FLYW Flywire | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24 -16.1% | $34.00 ➝ $27.00 | Buy ➝ Buy | |
FLYW Flywire | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24 -16.1% | $41.00 ➝ $34.00 | Outperform ➝ Outperform | |
FLYW Flywire | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24 -16.1% | $36.00 ➝ $33.00 | Buy ➝ Buy | |
FLYW Flywire | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24 -16.1% | $34.00 ➝ $26.00 | Buy ➝ Buy | |
FLYW Flywire | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24 -16.1% | | Outperform | |
FMC FMC | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.83 -2.9% | $79.00 ➝ $81.00 | Overweight ➝ Overweight | |
FMC FMC | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.83 -2.9% | $65.00 ➝ $68.00 | Equal Weight ➝ Equal Weight | |
FRSH Freshworks | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.82 -3.1% | $30.00 | Buy ➝ Buy | |
FWRG First Watch Restaurant Group | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.85 +1.6% | $29.00 ➝ $27.00 | Overweight ➝ Overweight | |
FWRG First Watch Restaurant Group | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.85 +1.6% | $26.00 ➝ $25.00 | Hold ➝ Hold | |
GBDC Golub Capital BDC | Downgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.60 -1.4% | | Outperform ➝ Market Perform | |
GEO The GEO Group | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.62 -0.1% | $22.00 ➝ $20.00 | Outperform ➝ Outperform | |
GFS GLOBALFOUNDRIES | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36 -1.7% | | Hold | |
GFS GLOBALFOUNDRIES | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36 -1.7% | $48.00 ➝ $50.00 | Neutral ➝ Neutral | |
GFS GLOBALFOUNDRIES | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36 -1.7% | $62.00 ➝ $63.00 | Overweight ➝ Overweight | |
GMED Globus Medical | Target Raised by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.61 +20.0% | $60.00 ➝ $63.00 | Buy ➝ Buy | |
GMED Globus Medical | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.61 +20.0% | $55.00 ➝ $60.00 | Neutral ➝ Neutral | |
GMED Globus Medical | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.61 +20.0% | | Hold | |
GMED Globus Medical | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.61 +20.0% | $64.00 ➝ $70.00 | Buy ➝ Buy | |
GO Grocery Outlet | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.88 -19.4% | $30.00 ➝ $27.00 | Neutral ➝ Neutral | |
GO Grocery Outlet | Target Lowered by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.88 -19.4% | $37.00 ➝ $31.00 | Outperform | |
GOLF Acushnet | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.99 -3.7% | $62.00 ➝ $63.00 | Hold ➝ Hold | |
RSVP: Charles Payne’s Cash Flow Workshop (Ad) Are you ready to find untapped value in the stocks you already own…
Without selling a single share…
Then you need to know these Cash Flow Trade Strategies. Register For Free Now! |
GOSS Gossamer Bio | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.76 +2.7% | $4.00 | Outperform ➝ Outperform | |
GPRO GoPro | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Reese Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.71 -7.6% | $2.00 | Neutral ➝ Neutral | |
GT Goodyear Tire & Rubber | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.67 +2.0% | $16.80 ➝ $15.90 | Buy ➝ Buy | |
GTLS Chart Industries | Initiated by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.88 -2.3% | $193.00 | Equal Weight ➝ Equal Weight | |
GTN Gray Television | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74 +0.6% | $11.00 ➝ $13.00 | Buy ➝ Buy | |
GTN Gray Television | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74 +0.6% | $5.50 ➝ $6.00 | Underweight ➝ Underweight | |
GWH ESS Tech | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.79 -14.1% | $2.50 ➝ $2.00 | Buy ➝ Buy | |
HALO Halozyme Therapeutics | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.01 +1.9% | $72.00 ➝ $71.00 | Market Outperform ➝ Market Outperform | |
HCKT The Hackett Group | Target Lowered by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.56 -2.9% | $28.00 ➝ $26.00 | Outperform ➝ Outperform | |
HLMN Hillman Solutions | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.59 +0.1% | $10.00 ➝ $11.00 | Outperform ➝ Outperform | |
HR Healthcare Realty Trust | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.32 -0.6% | $15.00 ➝ $16.00 | Neutral ➝ Neutral | |
HRT HireRight | Upgraded by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Nicholas Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.33 -0.2% | | Market Perform ➝ Outperform | |
HRTX Heron Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.01 +4.9% | $5.00 | Buy ➝ Buy | |
HSIC Henry Schein | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.76 +2.2% | $82.00 ➝ $80.00 | Neutral ➝ Neutral | |
HSIC Henry Schein | Target Raised by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.76 +2.2% | $90.00 ➝ $92.00 | Outperform ➝ Outperform | |
HXL Hexcel | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.65 +2.1% | $81.00 ➝ $95.00 | Equal Weight ➝ Overweight | |
ICHR Ichor | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86 -2.8% | $42.00 | Hold | |
ICHR Ichor | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86 -2.8% | $42.00 ➝ $48.00 | Buy ➝ Buy | |
ICHR Ichor | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86 -2.8% | $55.00 ➝ $50.00 | Buy ➝ Buy | |
IDYA IDEAYA Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.41 -3.1% | $52.00 | Outperform ➝ Outperform | |
IFF International Flavors & Fragrances | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23 +3.1% | $100.00 ➝ $110.00 | Overweight ➝ Overweight | |
IFF International Flavors & Fragrances | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23 +3.1% | $100.00 ➝ $108.00 | Buy ➝ Buy | |
IFF International Flavors & Fragrances | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23 +3.1% | $82.00 ➝ $93.00 | Equal Weight ➝ Equal Weight | |
IFF International Flavors & Fragrances | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23 +3.1% | $75.00 ➝ $100.00 | Neutral ➝ Overweight | |
IFF International Flavors & Fragrances | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23 +3.1% | $100.00 ➝ $110.00 | Outperform ➝ Outperform | |
IMRX Immuneering | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.63 +4.5% | $15.00 | Buy ➝ Buy | |
INGN Inogen | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.24 +12.9% | | Hold | |
INGN Inogen | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.24 +12.9% | $6.00 ➝ $7.00 | Hold ➝ Hold | |
INSP Inspire Medical Systems | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $164.47 -33.0% | $265.00 ➝ $225.00 | Buy ➝ Neutral | |
INSP Inspire Medical Systems | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $164.47 -33.0% | $250.00 ➝ $255.00 | Overweight ➝ Overweight | |
INTA Intapp | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.15 +9.0% | $55.00 ➝ $50.00 | Buy ➝ Buy | |
INZY Inozyme Pharma | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.64 +0.9% | $23.00 | Buy ➝ Buy | |
IONS Ionis Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.16 -1.9% | $60.00 | Buy ➝ Buy | |
IONS Ionis Pharmaceuticals | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.16 -1.9% | $85.00 ➝ $82.00 | Overweight ➝ Overweight | |
ITT ITT | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.41 +1.3% | $135.00 ➝ $158.00 | Buy ➝ Buy | |
J Jacobs Solutions | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.52 -2.2% | $154.00 ➝ $153.00 | Hold ➝ Hold | |
J Jacobs Solutions | Downgraded by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.52 -2.2% | | Outperform ➝ Market Perform | |
J Jacobs Solutions | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.52 -2.2% | $168.00 ➝ $163.00 | Outperform ➝ Outperform | |
JACK Jack in the Box | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.23 +0.6% | $81.00 ➝ $67.00 | Neutral ➝ Neutral | |
JANX Janux Therapeutics | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.37 -10.0% | $53.00 ➝ $74.00 | Outperform ➝ Outperform | |
JELD JELD-WEN | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.97 -2.6% | $16.00 ➝ $13.00 | Underperform ➝ Underperform | |
JELD JELD-WEN | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.97 -2.6% | $22.00 ➝ $19.00 | Buy ➝ Buy | |
JKHY Jack Henry & Associates | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.59 0.0% | | Outperform | |
JLL Jones Lang LaSalle | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $191.09 +0.4% | $190.00 ➝ $200.00 | Market Perform ➝ Market Perform | |
KIDS OrthoPediatrics | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.18 -4.4% | $35.00 ➝ $38.00 | Hold ➝ Hold | |
KLG WK Kellogg | Downgraded by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.95 -9.6% | $20.00 | Neutral ➝ Underperform | |
KLG WK Kellogg | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.95 -9.6% | $20.00 ➝ $22.00 | Hold ➝ Hold | |
KLG WK Kellogg | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.95 -9.6% | $21.00 ➝ $23.00 | In-Line ➝ In-Line | |
KLG WK Kellogg | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.95 -9.6% | $13.00 ➝ $24.00 | Hold ➝ Hold | |
KVUE Kenvue | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.45 +1.8% | $20.00 ➝ $21.00 | Hold ➝ Hold | |
LCID Lucid Group | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71 +3.4% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
LGND Ligand Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.36 +9.8% | $144.00 | Buy ➝ Buy | |
LOPE Grand Canyon Education | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08 +5.2% | $165.00 ➝ $170.00 | Outperform ➝ Outperform | |
LOPE Grand Canyon Education | Target Raised by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08 +5.2% | $160.00 ➝ $165.00 | Outperform ➝ Outperform | |
LOPE Grand Canyon Education | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08 +5.2% | $150.00 ➝ $155.00 | Outperform ➝ Outperform | |
LPRO Open Lending | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 +5.3% | $7.00 ➝ $6.00 | Hold ➝ Hold | |
LPRO Open Lending | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 +5.3% | $8.00 ➝ $7.00 | Buy ➝ Buy | |
LULU Lululemon Athletica | Initiated by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $345.61 -1.2% | $425.00 | Buy | |
LYFT Lyft | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
LYFT Lyft | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | | Hold | |
LYFT Lyft | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $18.00 | Hold ➝ Hold | |
LYFT Lyft | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $18.00 | Market Perform ➝ Market Perform | |
LYFT Lyft | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
LYFT Lyft | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $14.00 ➝ $16.00 | Hold ➝ Hold | |
LYFT Lyft | Target Raised by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $19.00 | Market Perform ➝ Market Perform | |
LYFT Lyft | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $22.00 ➝ $23.00 | Overweight ➝ Overweight | |
LYFT Lyft | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $17.00 ➝ $20.00 | Equal Weight ➝ Equal Weight | |
LYFT Lyft | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $23.00 ➝ $24.00 | Outperform ➝ Outperform | |
LYFT Lyft | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78 +7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
MARA Marathon Digital | Target Lowered by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.09 -0.6% | $30.00 ➝ $21.00 | Neutral ➝ Neutral | |
MASI Masimo | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.02 -11.8% | | Hold | |
MASI Masimo | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.02 -11.8% | $117.00 ➝ $126.00 | Neutral ➝ Neutral | |
MBWM Mercantile Bank | Downgraded by | Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.56 +0.2% | | Buy ➝ Neutral | |
MCK McKesson | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.22 -0.5% | $603.00 ➝ $671.00 | Outperform ➝ Outperform | |
MCK McKesson | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.22 -0.5% | $620.00 ➝ $630.00 | Buy ➝ Buy | |
MCK McKesson | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.22 -0.5% | $571.00 ➝ $596.00 | Overweight ➝ Overweight | |
MCK McKesson | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.22 -0.5% | $563.00 ➝ $652.00 | Buy ➝ Buy | |
MCK McKesson | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.22 -0.5% | $590.00 ➝ $600.00 | Outperform ➝ Outperform | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04 -4.6% | $425.00 ➝ $390.00 | Buy ➝ Buy | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04 -4.6% | $397.00 ➝ $381.00 | Market Outperform ➝ Market Outperform | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04 -4.6% | $389.00 ➝ $382.00 | Buy ➝ Buy | |
MKTX MarketAxess | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21 +0.7% | $236.00 ➝ $225.00 | Equal Weight ➝ Equal Weight | |
MKTX MarketAxess | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21 +0.7% | $235.00 ➝ $230.00 | Market Perform ➝ Market Perform | |
MKTX MarketAxess | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21 +0.7% | $305.00 ➝ $285.00 | Buy ➝ Buy | |
ML MoneyLion | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.83 +8.8% | $90.00 ➝ $100.00 | Buy ➝ Buy | |
ML MoneyLion | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.83 +8.8% | $100.00 ➝ $105.00 | Buy ➝ Buy | |
MLTX MoonLake Immunotherapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.63 -2.4% | $100.00 | Buy ➝ Buy | |
MLTX MoonLake Immunotherapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.63 -2.4% | $66.00 | Buy ➝ Buy | |
MQ Marqeta | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84 +0.2% | | Outperform | |
MQ Marqeta | Target Raised by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84 +0.2% | $7.50 ➝ $8.00 | Buy | |
MQ Marqeta | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84 +0.2% | $6.00 | Neutral ➝ Neutral | |
MRCY Mercury Systems | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.77 -1.2% | $28.00 ➝ $26.00 | Hold ➝ Hold | |
MTH Meritage Homes | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $180.59 +0.0% | $180.00 ➝ $195.00 | Market Perform ➝ Market Perform | |
MVBF MVB Financial | Target Lowered by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.37 -1.4% | $27.00 ➝ $23.00 | Outperform | |
MWA Mueller Water Products | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 +5.1% | $18.00 ➝ $24.00 | Neutral ➝ Neutral | |
MWA Mueller Water Products | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 +5.1% | $17.00 ➝ $20.00 | Sector Perform ➝ Sector Perform | |
MYGN Myriad Genetics | Upgraded by | SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.95 +21.1% | $25.00 ➝ $35.00 | Market Perform ➝ Outperform | |
NDAQ Nasdaq | Downgraded by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.91 -1.6% | $76.00 ➝ $64.00 | Buy ➝ Neutral | |
NGVT Ingevity | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.00 +0.5% | $50.00 ➝ $55.00 | Market Perform ➝ Market Perform | |
NRBO NeuroBo Pharmaceuticals | Initiated by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.93 +2.3% | $10.00 | Buy | |
NRDY Nerdy | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.41 -9.1% | $4.00 | Buy ➝ Buy | |
NRG NRG Energy | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.82 +3.3% | $73.00 ➝ $82.00 | Market Perform ➝ Market Perform | |
NRG NRG Energy | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.82 +3.3% | $85.00 ➝ $100.00 | Overweight ➝ Overweight | |
NTNX Nutanix | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.21 +1.4% | $72.00 | Market Perform ➝ Outperform | |
NVCT Nuvectis Pharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.43 -10.6% | $21.00 | Buy ➝ Buy | |
NVEI Nuvei | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.48 +0.4% | $32.00 ➝ $34.00 | Overweight ➝ Neutral | |
NVRO Nevro | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.17 -11.8% | $15.00 ➝ $12.00 | Underweight ➝ Underweight | |
NVRO Nevro | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.17 -11.8% | $14.00 ➝ $13.00 | Equal Weight ➝ Equal Weight | |
NVRO Nevro | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.17 -11.8% | $17.00 ➝ $11.00 | Hold ➝ Hold | |
NYMT New York Mortgage Trust | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.02 -2.1% | $7.50 ➝ $6.00 | Neutral ➝ Neutral | |
OCN Ocwen Financial | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.41 +1.0% | $28.00 ➝ $32.00 | Market Perform ➝ Market Perform | |
OCUL Ocular Therapeutix | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75 -3.0% | $11.00 ➝ $7.00 | Hold ➝ Hold | |
OCUL Ocular Therapeutix | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75 -3.0% | $16.00 ➝ $14.00 | Buy ➝ Buy | |
OCUL Ocular Therapeutix | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75 -3.0% | $24.00 ➝ $22.00 | Market Outperform ➝ Market Outperform | |
ODFL Old Dominion Freight Line | Upgraded by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $181.70 -1.7% | $205.00 | Neutral ➝ Outperform | |
OFIX Orthofix Medical | Upgraded by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.90 +7.3% | $15.00 ➝ $20.00 | Neutral ➝ Buy | |
ONTF ON24 | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.47 -4.3% | | Hold | |
OPAD Offerpad Solutions | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.87 +1.8% | $6.25 ➝ $6.00 | Underperform ➝ Underperform | |
OPK OPKO Health | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.25 -3.8% | $3.00 | Buy ➝ Buy | |
OXY Occidental Petroleum | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.69 -2.1% | $70.00 ➝ $71.00 | Neutral ➝ Neutral | |
PAA Plains All American Pipeline | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.66 +1.0% | $19.00 ➝ $20.00 | Overweight ➝ Overweight | |
PAGP Plains GP | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.52 +1.4% | $19.00 ➝ $20.00 | Overweight ➝ Overweight | |
PARR Par Pacific | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.07 -2.4% | $45.00 ➝ $42.00 | Buy ➝ Buy | |
PAYS Paysign | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.57 -2.1% | $5.50 ➝ $6.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65 +11.8% | $45.00 ➝ $43.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65 +11.8% | $57.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65 +11.8% | $40.00 ➝ $38.00 | Overweight ➝ Overweight | |
PEN Penumbra | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.07 -3.3% | $284.00 ➝ $272.00 | Buy ➝ Buy | |
PEN Penumbra | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.07 -3.3% | $290.00 ➝ $260.00 | Overweight ➝ Overweight | |
PEN Penumbra | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.07 -3.3% | | Hold | |
PINC Premier | Downgraded by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61 +1.0% | $27.00 ➝ $21.00 | Buy ➝ Hold | |
PINC Premier | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61 +1.0% | $25.00 ➝ $22.00 | Neutral ➝ Neutral | |
PINC Premier | Reiterated by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61 +1.0% | $27.00 ➝ $21.00 | Buy ➝ Hold | |
PINC Premier | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61 +1.0% | $24.00 ➝ $22.00 | Neutral ➝ Neutral | |
PLBY PLBY Group | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.04 +3.0% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
PR Permian Resources | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.26 -1.7% | $20.00 ➝ $21.00 | Buy ➝ Buy | |
PRA ProAssurance | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.72 -2.9% | $14.00 ➝ $16.00 | Hold ➝ Hold | |
PRO PROS | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.58 -7.2% | $40.00 | Buy ➝ Buy | |
PRPL Purple Innovation | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.53 -8.9% | $2.25 | Outperform ➝ Outperform | |
PRTS CarParts.com | Reiterated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.13 -2.6% | $4.00 ➝ $2.00 | Buy ➝ Hold | |
PTGX Protagonist Therapeutics | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.11 +5.1% | $42.00 ➝ $45.00 | Market Outperform ➝ Market Outperform | |
PTLO Portillo's | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.35 -2.5% | $17.00 ➝ $15.00 | Outperform ➝ Outperform | |
PTLO Portillo's | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.35 -2.5% | $18.00 ➝ $13.00 | Neutral ➝ Neutral | |
PUBM PubMatic | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.58 -6.0% | $26.00 ➝ $30.00 | Outperform ➝ Outperform | |
PWSC PowerSchool | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15 +15.1% | $28.00 ➝ $23.00 | Overweight ➝ Overweight | |
PWSC PowerSchool | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15 +15.1% | $26.00 | Buy ➝ Buy | |
PWSC PowerSchool | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15 +15.1% | $25.00 ➝ $20.00 | Neutral ➝ Neutral | |
QLYS Qualys | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $149.75 -9.8% | $175.00 ➝ $165.00 | Hold ➝ Hold | |
QLYS Qualys | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $149.75 -9.8% | $175.00 ➝ $170.00 | Neutral ➝ Neutral | |
QURE uniQure | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.89 +1.5% | $7.00 ➝ $6.00 | Neutral ➝ Neutral | |
QURE uniQure | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.89 +1.5% | $25.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $53.00 ➝ $63.00 | Market Outperform ➝ Market Outperform | |
RDDT Reddit | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $53.00 ➝ $65.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $40.00 ➝ $45.00 | Underperform ➝ Underperform | |
RDDT Reddit | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $50.00 ➝ $61.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $50.00 ➝ $65.00 | Overweight ➝ Overweight | |
RDDT Reddit | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $50.00 ➝ $59.00 | Neutral ➝ Neutral | |
RDDT Reddit | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40 +4.0% | $55.00 ➝ $63.00 | Buy ➝ Buy | |
RDFN Redfin | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25 -1.9% | | Hold | |
RDFN Redfin | Upgraded by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25 -1.9% | $8.00 ➝ $9.00 | Equal Weight ➝ Overweight | |
RDFN Redfin | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25 -1.9% | $8.00 | Neutral | |
RDFN Redfin | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25 -1.9% | $8.00 ➝ $7.00 | Neutral ➝ Neutral | |
RDY Dr. Reddy's Laboratories | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.46 +0.2% | $80.00 ➝ $81.00 | Overweight ➝ Overweight | |
REAL RealReal | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +7.9% | $3.00 ➝ $4.50 | Outperform ➝ Outperform | |
REAL RealReal | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +7.9% | $6.00 | Buy ➝ Buy | |
REAL RealReal | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08 +7.9% | $2.00 ➝ $4.00 | Equal Weight ➝ Equal Weight | |
RIGL Rigel Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.99 -16.8% | $15.00 | Buy ➝ Buy | |
RIVN Rivian Automotive | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27 +0.2% | $12.00 ➝ $11.00 | Neutral ➝ Neutral | |
RIVN Rivian Automotive | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27 +0.2% | $13.00 | Buy ➝ Buy | |
RIVN Rivian Automotive | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27 +0.2% | $14.00 ➝ $10.00 | Equal Weight ➝ Equal Weight | |
RIVN Rivian Automotive | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27 +0.2% | $23.00 ➝ $15.00 | Overweight ➝ Overweight | |
RNAC Cartesian Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.25 +0.2% | $42.00 | Buy ➝ Buy | |
RNG RingCentral | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38 +14.6% | $31.00 ➝ $33.00 | Equal Weight ➝ Equal Weight | |
RNG RingCentral | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38 +14.6% | $31.00 ➝ $32.00 | Neutral ➝ Neutral | |
RNG RingCentral | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38 +14.6% | $37.00 ➝ $40.00 | Neutral ➝ Neutral | |
RNG RingCentral | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38 +14.6% | $36.00 ➝ $38.00 | Buy ➝ Buy | |
RNG RingCentral | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38 +14.6% | $42.00 | Buy ➝ Buy | |
ROK Rockwell Automation | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.54 +0.6% | $310.00 ➝ $304.00 | Outperform ➝ Outperform | |
ROK Rockwell Automation | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.54 +0.6% | $265.00 ➝ $260.00 | Neutral ➝ Neutral | |
ROK Rockwell Automation | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.54 +0.6% | $320.00 ➝ $312.00 | Overweight ➝ Overweight | |
ROK Rockwell Automation | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.54 +0.6% | $265.00 ➝ $260.00 | Underweight ➝ Underweight | |
ROK Rockwell Automation | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.54 +0.6% | $322.00 ➝ $316.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $65.00 ➝ $52.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $60.00 ➝ $49.00 | Equal Weight ➝ Equal Weight | |
RPD Rapid7 | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $56.00 ➝ $45.00 | Neutral ➝ Neutral | |
RPD Rapid7 | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $60.00 ➝ $52.00 | Hold ➝ Hold | |
RPD Rapid7 | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $70.00 ➝ $57.00 | Outperform ➝ Outperform | |
RPD Rapid7 | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $50.00 ➝ $45.00 | Hold ➝ Hold | |
RPD Rapid7 | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $63.00 ➝ $51.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $62.00 ➝ $47.00 | Neutral ➝ Neutral | |
RPD Rapid7 | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $62.00 ➝ $56.00 | Outperform ➝ Outperform | |
RPD Rapid7 | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00 -17.0% | $70.00 ➝ $65.00 | Buy ➝ Buy | |
RRR Red Rock Resorts | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22 -7.6% | $61.00 ➝ $59.00 | Hold ➝ Hold | |
RRR Red Rock Resorts | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22 -7.6% | $69.00 ➝ $66.00 | Buy ➝ Buy | |
RRR Red Rock Resorts | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22 -7.6% | $66.00 ➝ $63.00 | Overweight ➝ Overweight | |
RRR Red Rock Resorts | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22 -7.6% | $66.00 ➝ $65.00 | Market Outperform ➝ Market Outperform | |
RRR Red Rock Resorts | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22 -7.6% | $64.00 ➝ $63.00 | Overweight ➝ Overweight | |
RRX Regal Rexnord | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.35 +0.1% | $203.00 ➝ $199.00 | Overweight ➝ Overweight | |
RRX Regal Rexnord | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.35 +0.1% | $205.00 ➝ $208.00 | Outperform ➝ Outperform | |
RVLV Revolve Group | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $19.00 ➝ $23.00 | Neutral ➝ Neutral | |
RVLV Revolve Group | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $23.00 ➝ $25.00 | Buy ➝ Buy | |
RVLV Revolve Group | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $13.00 ➝ $15.00 | Underweight ➝ Underweight | |
RVLV Revolve Group | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $21.00 ➝ $26.00 | Buy ➝ Buy | |
RVLV Revolve Group | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $17.00 ➝ $19.00 | Neutral ➝ Neutral | |
RVLV Revolve Group | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.69 +2.6% | $13.00 ➝ $15.00 | Market Perform ➝ Market Perform | |
RWAY Runway Growth Finance | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32 -7.0% | $13.00 ➝ $12.00 | Equal Weight ➝ Equal Weight | |
RWAY Runway Growth Finance | Downgraded by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32 -7.0% | $12.75 | Buy ➝ Neutral | |
RYTM Rhythm Pharmaceuticals | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.92 -1.1% | $49.00 ➝ $42.00 | Buy ➝ Neutral | |
RYTM Rhythm Pharmaceuticals | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.92 -1.1% | $80.00 ➝ $79.00 | Buy ➝ Buy | |
SAFE Safehold | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.28 -2.6% | $32.00 ➝ $29.00 | Outperform ➝ Outperform | |
SAM Boston Beer | Upgraded by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $281.64 +3.1% | $273.00 | Sell ➝ Hold | |
SAR Saratoga Investment | Downgraded by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.87 -2.5% | $24.00 ➝ $23.00 | Outperform ➝ Market Perform | |
SAVE Spirit Airlines | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Stathoulopoul Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.41 +2.4% | $4.00 ➝ $3.00 | Negative ➝ Negative | |
SCOR comScore | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.30 -1.2% | $25.00 | Buy ➝ Buy | |
SCOR comScore | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.30 -1.2% | $24.00 ➝ $18.00 | Buy ➝ Buy | |
SEAT Vivid Seats | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -1.1% | $12.00 ➝ $10.00 | Buy ➝ Buy | |
SEAT Vivid Seats | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35 -1.1% | $7.00 ➝ $9.00 | Buy ➝ Buy | |
SEMR Semrush | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38 +5.0% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
SGRY Surgery Partners | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.17 -2.2% | $42.00 ➝ $38.00 | Buy ➝ Buy | |
SHLS Shoals Technologies Group | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $24.00 ➝ $14.00 | Overweight ➝ Overweight | |
SHLS Shoals Technologies Group | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $14.00 ➝ $11.00 | Overweight ➝ Overweight | |
SHLS Shoals Technologies Group | Reiterated by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $12.00 ➝ $6.00 | Market Perform ➝ Underperform | |
SHLS Shoals Technologies Group | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $16.00 ➝ $13.00 | Buy ➝ Buy | |
SHLS Shoals Technologies Group | Downgraded by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $15.00 ➝ $8.00 | Buy ➝ Neutral | |
SHLS Shoals Technologies Group | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51 -14.7% | $15.00 ➝ $11.00 | Buy ➝ Buy | |
SKM SK Telecom | Upgraded by | Nomura Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.79 +0.3% | | Reduce ➝ Neutral | |
SKWD Skyward Specialty Insurance Group | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.16 -1.2% | $44.00 ➝ $46.00 | Outperform ➝ Outperform | |
SLDP Solid Power | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.74 -2.8% | $3.00 | Buy ➝ Buy | |
SNCY Sun Country Airlines | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.34 -8.0% | $22.00 ➝ $17.00 | Buy | |
SPCE Virgin Galactic | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.00 -1.0% | $2.00 ➝ $1.10 | Neutral ➝ Neutral | |
SPNS Sapiens International | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.52 +6.8% | $38.00 | Buy ➝ Buy | |
SPR Spirit AeroSystems | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.89 -6.1% | $33.00 ➝ $35.00 | Sector Perform ➝ Sector Perform | |
SPR Spirit AeroSystems | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.89 -6.1% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
SPXC SPX Technologies | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.92 -1.6% | $126.00 ➝ $142.00 | Neutral ➝ Neutral | |
SQSP Squarespace | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.79 +2.4% | $40.00 ➝ $45.00 | Overweight ➝ Overweight | |
SQSP Squarespace | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.79 +2.4% | $35.00 ➝ $38.00 | Sector Perform ➝ Sector Perform | |
SQSP Squarespace | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.79 +2.4% | $37.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
SRE Sempra | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.23 +1.7% | $79.00 ➝ $84.00 | Overweight ➝ Overweight | |
SRRK Scholar Rock | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50 -1.3% | $30.00 | Buy ➝ Buy | |
STAA STAAR Surgical | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -12.1% | $53.00 ➝ $55.00 | Buy ➝ Buy | |
STAA STAAR Surgical | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -12.1% | | Hold | |
STAA STAAR Surgical | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -12.1% | $33.00 ➝ $40.00 | Neutral ➝ Neutral | |
STAA STAAR Surgical | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02 -12.1% | $46.00 ➝ $43.00 | Hold ➝ Hold | |
STEM Stem | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.37 +5.4% | $5.00 ➝ $2.50 | Buy ➝ Buy | |
STKS ONE Group Hospitality | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.63 -3.5% | $9.00 | Overweight ➝ Overweight | |
STRO Sutro Biopharma | Initiated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.28 +0.7% | $12.00 | Buy | |
SYM Symbotic | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.36 +4.0% | $55.00 ➝ $60.00 | Buy ➝ Buy | |
TACT TransAct Technologies | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.87 -1.3% | $9.00 ➝ $7.50 | Buy ➝ Buy | |
TBI TrueBlue | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.55 -0.2% | $15.00 ➝ $13.00 | Outperform ➝ Outperform | |
TBLA Taboola.com | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.54 +0.2% | $6.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,300.00 ➝ $1,400.00 | Outperform ➝ Outperform | |
TDG TransDigm Group | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,260.00 ➝ $1,390.00 | Equal Weight ➝ Equal Weight | |
TDG TransDigm Group | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,300.00 ➝ $1,400.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,290.00 ➝ $1,357.00 | Outperform ➝ Outperform | |
TDG TransDigm Group | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,100.00 ➝ $1,200.00 | Neutral ➝ Neutral | |
TDG TransDigm Group | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,267.00 ➝ $1,425.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00 +0.4% | $1,302.00 ➝ $1,403.00 | Neutral ➝ Neutral | |
TFC Truist Financial | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.39 +0.7% | $45.00 ➝ $46.00 | Outperform ➝ Outperform | |
TFC Truist Financial | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.39 +0.7% | $40.00 ➝ $41.00 | Hold ➝ Hold | |
THS TreeHouse Foods | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.79 -2.0% | $39.00 ➝ $36.00 | Equal Weight ➝ Equal Weight | |
TMCI Treace Medical Concepts | Downgraded by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | $17.00 ➝ $7.00 | Buy ➝ Hold | |
TMCI Treace Medical Concepts | Downgraded by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | | Buy ➝ Neutral | |
TMCI Treace Medical Concepts | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | $15.00 ➝ $8.00 | Overweight ➝ Neutral | |
TMCI Treace Medical Concepts | Downgraded by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | $15.00 ➝ $6.00 | Buy ➝ Hold | |
TMCI Treace Medical Concepts | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | $17.00 ➝ $16.00 | Buy ➝ Buy | |
TMCI Treace Medical Concepts | Downgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 -62.5% | $15.00 ➝ $5.50 | Overweight ➝ Equal Weight | |
TOST Toast | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82 +13.0% | $25.00 ➝ $26.00 | Market Perform ➝ Market Perform | |
TOST Toast | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82 +13.0% | $26.00 ➝ $30.00 | Buy ➝ Buy | |
TOST Toast | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82 +13.0% | $23.00 ➝ $27.00 | Sector Perform ➝ Sector Perform | |
TOST Toast | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82 +13.0% | $22.00 ➝ $28.00 | Buy ➝ Buy | |
TOST Toast | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82 +13.0% | $17.00 ➝ $19.00 | Underweight ➝ Underweight | |
TPX Tempur Sealy International | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.12 +0.1% | $66.00 | Outperform ➝ Outperform | |
TRVI Trevi Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.64 -9.0% | $8.00 | Buy ➝ Buy | |
TWKS Thoughtworks | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07 +1.7% | $5.00 ➝ $6.00 | Outperform ➝ Outperform | |
TWKS Thoughtworks | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07 +1.7% | $6.00 | Outperform ➝ Outperform | |
TWKS Thoughtworks | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07 +1.7% | $2.50 ➝ $3.25 | Neutral ➝ Neutral | |
TWLO Twilio | Target Lowered by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $69.00 ➝ $63.00 | Neutral ➝ Neutral | |
TWLO Twilio | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $90.00 ➝ $85.00 | Buy ➝ Buy | |
TWLO Twilio | Target Lowered by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $70.00 ➝ $68.00 | Market Perform ➝ Market Perform | |
TWLO Twilio | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $78.00 ➝ $79.00 | Overweight ➝ Overweight | |
TWLO Twilio | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $71.00 | Buy ➝ Buy | |
TWLO Twilio | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.61 -7.5% | $70.00 ➝ $65.00 | Neutral ➝ Neutral | |
UBER Uber Technologies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.40 -5.7% | $90.00 | Buy ➝ Buy | |
UBER Uber Technologies | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.40 -5.7% | $85.00 | Outperform | |
UL Unilever | Target Raised by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.69 +0.1% | $58.00 ➝ $60.00 | Buy ➝ Buy | |
UPST Upstart | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11 -5.6% | | Hold | |
UPST Upstart | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11 -5.6% | $10.00 | Underperform ➝ Underperform | |
VAC Marriott Vacations Worldwide | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.56 -2.6% | $102.00 ➝ $106.00 | Equal Weight ➝ Equal Weight | |
VALN Valneva | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.24 -3.5% | $26.00 | Buy ➝ Buy | |
VCYT Veracyte | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.12 -4.3% | $33.00 ➝ $27.00 | Buy ➝ Buy | |
VECO Veeco Instruments | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.29 +4.8% | $43.00 ➝ $46.00 | Buy ➝ Buy | |
VECO Veeco Instruments | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.29 +4.8% | $33.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
VIGL Vigil Neuroscience | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78 +18.5% | $24.00 | Buy ➝ Buy | |
VIGL Vigil Neuroscience | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78 +18.5% | $22.00 | Outperform ➝ Outperform | |
VNO Vornado Realty Trust | Target Lowered by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.71 -2.1% | $28.00 ➝ $27.00 | Neutral ➝ Neutral | |
VPG Vishay Precision Group | Downgraded by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38 -6.4% | $37.00 ➝ $36.00 | Buy ➝ Neutral | |
VSCO Victoria's Secret & Co. | Downgraded by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.03 +0.6% | $15.00 ➝ $14.00 | Equal Weight ➝ Underweight | |
VVX V2X | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.93 +0.1% | $52.00 ➝ $56.00 | Hold ➝ Hold | |
VVX V2X | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.93 +0.1% | $50.00 ➝ $55.00 | Outperform ➝ Outperform | |
WAL Western Alliance Bancorporation | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.99 +1.3% | $70.00 | Outperform ➝ Outperform | |
WAT Waters | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80 -0.7% | $330.00 ➝ $332.00 | Hold ➝ Hold | |
WAT Waters | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80 -0.7% | $319.00 ➝ $312.00 | Neutral ➝ Neutral | |
WAT Waters | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80 -0.7% | $300.00 ➝ $295.00 | Underweight ➝ Underweight | |
WAT Waters | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80 -0.7% | $350.00 ➝ $358.00 | Hold ➝ Hold | |
WELL Welltower | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.42 +1.0% | $98.00 ➝ $105.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.32 +0.5% | $40.00 ➝ $43.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.32 +0.5% | $38.00 ➝ $39.00 | Neutral ➝ Neutral | |
WMS Advanced Drainage Systems | Initiated by | Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $168.19 +0.0% | $190.00 | Buy | |
WOW WideOpenWest | Downgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.66 +0.4% | | Outperform ➝ Market Perform | |
WWW Wolverine World Wide | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.73 +11.5% | $10.00 ➝ $10.00 | Market Perform ➝ Market Perform | |
WYNN Wynn Resorts | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75 -1.5% | $125.00 ➝ $128.00 | Overweight ➝ Overweight | |
WYNN Wynn Resorts | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75 -1.5% | $135.00 ➝ $138.00 | Buy ➝ Buy | |
WYNN Wynn Resorts | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75 -1.5% | $132.00 ➝ $138.00 | Buy ➝ Buy | |
YOU Clear Secure | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.17 -5.0% | $40.00 | Buy ➝ Buy | |
YOU Clear Secure | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.17 -5.0% | $21.00 | Neutral ➝ Neutral | |
ZI ZoomInfo Technologies | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $28.00 ➝ $21.00 | Overweight ➝ Overweight | |
ZI ZoomInfo Technologies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $25.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $22.00 ➝ $20.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $19.00 ➝ $15.00 | Equal Weight ➝ Equal Weight | |
ZI ZoomInfo Technologies | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $20.00 ➝ $18.00 | Overweight ➝ Overweight | |
ZI ZoomInfo Technologies | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $24.00 ➝ $20.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $19.00 ➝ $16.00 | Neutral ➝ Neutral | |
ZI ZoomInfo Technologies | Downgraded by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $19.50 ➝ $12.00 | Neutral ➝ Sell | |
ZI ZoomInfo Technologies | Downgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $24.00 ➝ $15.00 | Overweight ➝ Neutral | |
ZI ZoomInfo Technologies | Downgraded by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14 -24.2% | $23.00 ➝ $14.00 | Buy ➝ Neutral | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.43 +1.0% | $36.00 ➝ $32.00 | Buy ➝ Buy | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.43 +1.0% | $46.00 ➝ $40.00 | Buy ➝ Buy | |
ZTS Zoetis | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $164.92 -2.1% | $230.00 ➝ $225.00 | Buy ➝ Buy | |